通往体内 CAR-T 成功之路:有前景的病毒载体与非病毒载体比较
On the road to in vivo CAR-T success: Comparing promising viral and non-viral vectors.
嵌合抗原受体(CAR)-T 细胞疗法在血液系统恶性肿瘤中已显示出显著疗效,多款产品获批用于临床。
83.5分
★★★★☆
站内排序·非疗效
ALL SOURCES
On the road to in vivo CAR-T success: Comparing promising viral and non-viral vectors.
嵌合抗原受体(CAR)-T 细胞疗法在血液系统恶性肿瘤中已显示出显著疗效,多款产品获批用于临床。
Distinct effector functions and synergy of CAR mRNA-engineered T cells and macrophages in the clearance of CD19(+) leukemia cells.
我们的研究结果凸显了 CAR-T 细胞优越的肿瘤细胞杀伤能力。
共 2 条
MEMBER ACCOUNT
登录成功会直接打开下一页。